GelMEDIX, Inc. — Form D/A
GelMEDIX, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2022-08-10. The offering totals $8.0M, of which $6.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-10
- Form: D/A
- Accession: 0001815624-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $6.4M
- Remaining: $1.6M
- Investors: 4
- Date of first sale: 2020-06-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-369335
Issuer
- Name: GelMEDIX, Inc.
- CIK: 0001815624
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 238 MAIN STREET, FIFTH FLOOR 238 Main Street, Fifth Floor, CAMBRIDGE, MA, 02142
- Phone: 941-228-8711
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Arthur Driscoll | Director | Cambridge, MA |
| Arthur Driscoll | Executive Officer | Cambridge, MA |
| Reza Dana | Director | Half Moon Bay, CA |
| Reza Dana | Related Person | Half Moon Bay, CA |
| Parinaz Motamedy | Director | Cambridge, MA |
| Parinaz Motamedy | Related Person | Cambridge, MA |
| Max Cotler | Director | Cambridge, MA |
| Max Cotler | Executive Officer | Cambridge, MA |
| Max Cotler | Related Person | Cambridge, MA |
| Nasim Annabi | Director | Cambridge, MA |
| Nasim Annabi | Related Person | Cambridge, MA |
| Michael Cima | Director | Cambridge, MA |
| Michael Cima | Related Person | Cambridge, MA |
| Jeffrey Behrens | Director | Newton, MA |
| Jeffrey Behrens | Executive Officer | Newton, MA |
Other filings by this issuer (7)
More